What’s the Best GLP-1 for Weight Loss in 2025?
A Physician-Led Telehealth Solution for Employers, Organizations, & Institutions
As healthcare costs rise and workforce wellness takes center stage, forward-thinking organizations are turning to a new solution: virtual GLP-1 weight loss programs. These physician-supervised treatments, delivered via telemedicine, help employees and residents safely lose weight, manage chronic disease, and improve long-term health outcomes without the red tape of traditional insurance-based care.
DevotedDOC operates a B2B-ready care model built to deliver GLP-1 services at scale for employers, correctional health systems, municipalities, and clinic networks. This guide explains how GLP-1 medications work, outlines responsible delivery standards, and details how organizations can implement these programs through a trusted telehealth partner whether supporting a large workforce or managing care in high-accountability environments.
What Are GLP-1 Medications & Why Do They Work?
GLP-1 (glucagon-like peptide-1) receptor agonists form a class of medications that clinicians originally developed to help manage type 2 diabetes. These medications mimic a hormone that slows digestion, improves insulin sensitivity, and reduces appetite. As a result, clinicians use them as powerful tools for medically supervised weight loss.
Common GLP-1 medications prescribed in 2025 include:
- Semaglutide (Wegovy®, Ozempic®) Tirzepatide (Mounjaro®) Liraglutide (Saxenda®)
Peer-reviewed clinical trials published in journals such as The New England Journal of Medicine and JAMA document average body weight reductions of approximately 10–22% over 6–12 months when GLP-1 medications are combined with lifestyle support and ongoing physician oversight.
Note: Ozempic, Wegovy, Mounjaro, and Saxenda are registered trademarks of their respective manufacturers. No affiliation with or endorsement by these companies is claimed by DevotedDOc.
Why Employers & Institutions Are Leaning In
Obesity isn’t just a personal challenge, it’s a public health issue that affects workforce performance, absenteeism, and healthcare utilization. According to the CDC, obesity-related absenteeism alone costs U.S. employers more than $13 billion annually.
Offering a telehealth-based GLP-1 program provides:
- Reduced healthcare claims and chronic disease burden
- Lower absenteeism and presenteeism
- Better retention and morale
- Private, stigma-free care employees and residents can access from home or facility
Best of all? It’s turn-key. No in-house staff or pharmacy logistics required
How DevotedDOC’s Virtual GLP-1 Program Works
Our physician-led process delivers streamlined care designed for high-compliance environments.
1. Screening & Eligibility
Firstly, individuals complete a virtual intake with a licensed DevotedDOC provider. We assess:
- BMI ≥30, or ≥27 with a comorbidity
- Full medical history
- Current prescriptions & labs
2. Physician Consultation
A board-certified physician delivers care through secure video appointments. Moreover, there are no mid-level-only clinics. As a result, assessments are never rushed.
3. Labs & Prescriptions
We coordinate local lab work as needed. Then, approved patients are prescribed a brand-name GLP-1 medication, with options sent to their preferred pharmacy or shipped via our pharmacy partners.
4. Monthly Clinical Oversight
Ongoing support includes:
- Medication adjustments
- Lifestyle guidance
- Weight tracking and adherence checks
5. Institutional Onboarding
We work with HR leaders, jail medical staff, and municipalities to implement group programs with simple billing, easy scheduling, and, in addition, a dedicated account manager.
Moreover, cash-pay model available to avoid prior authorization and coverage delays.
Why Choose DevotedDOc
Many virtual care companies offer GLP-1 prescriptions, but few design their services for large employer groups. DevotedDOc focuses on medical quality, operational integrity, and clinical oversight, rather than mass-market volume.
Here’s what sets us apart:
Frequently Asked Questions
Semaglutide (Wegovy, Ozempic), Tirzepatide (Mounjaro), and Liraglutide (Saxenda), based on clinical appropriateness and pharmacy availability.
We evaluate most patients within 24–48 hours. Also, prescriptions are sent the same day, subject to pharmacy fulfillment.
We operate primarily on a cash-pay basis to avoid denials, delays, and insurer restrictions. We cab obtain preauthorization depending on your medical history getting your medication costs reduced to $25 per month.
Yes. DevotedDOC currently operates nationally.
Where We Serve
Currently, DevotedDOC GLP-1 Program Locations are available nationally.
Also, we provide compliant, evidence-based weight loss care for city employers and county health directors.
Final Thoughts: The Future of Obesity Care Is Virtual and Physician-Led
GLP-1 medications are changing lives, but the way providers deliver them matters. At DevotedDOC, we don’t take shortcuts. Also, we believe in real doctors, real follow-up, and real results. Therefore, our B2B-first weight loss platform is built to scale across teams and clinical groups with the reporting, medical integrity, and access today’s leaders expect.
Let’s Talk
Organizations considering GLP-1 care for a workforce, resident population, or patient group:
Book a Free Institutional Consultation
Email: contact@devoteddoc.com
Call: 844-DOC-4-SUB
DevotedDOC. Built for better care.
